Local
Q&A: Might a UVA discovery reverse multiple sclerosis?
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Source: UVA Today

Discovery & Innovation Q&A: Might a UVA discovery reverse multiple sclerosis? By Mike Mather, [email protected] November 4, 2026 Facebook Twitter LinkedIn Email Dr. Jayakrishna Ambati, seated, has developed a drug that could reverse damage caused by multiple sclerosis. With him is Bradley Gelfand, who has a doctorate in biomedical engineering and works with Ambati. (Photo by Lathan Goumas, UVA Communications) Trending Discovery & Innovation Decades of work lead to a new Parkinson’s treatment University News UVA Health acquires State Farm site on Pantops Student Experience Love and basketball: A UVA romance comes full circle A drug developed by Dr. Jayakrishna Ambati of UVA’s School of Medicine has, in some cases, reversed the course of the disease – lost eyesight restored, lost movement regained.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at UVA Today